Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Nat Methods. 2018 Mar;15(3):183-186. doi: 10.1038/nmeth.4579. Epub 2018 Jan 22.
We describe a lentivirus-encoded chimeric receptor, termed extracellular vesicle (EV)-internalizing receptor (EVIR), which enables the selective uptake of cancer-cell-derived EVs by dendritic cells (DCs). The EVIR enhances DC presentation of EV-associated tumor antigens to CD8 T cells primarily through MHCI recycling and cross-dressing. EVIRs should facilitate exploring the mechanisms and implications of horizontal transfer of tumor antigens to antigen-presenting cells.
我们描述了一种慢病毒编码的嵌合受体,称为细胞外囊泡(EV)内化受体(EVIR),它使树突状细胞(DC)能够选择性摄取癌细胞衍生的 EV。EVIR 通过 MHCI 再循环和交叉装扮主要增强了 EV 相关肿瘤抗原向 CD8 T 细胞的呈递。EVIR 应该有助于探索肿瘤抗原向抗原呈递细胞水平转移的机制和意义。